Amidst the growing infection of the corona virus, countries around the world are waiting for its vaccine, on the other hand, companies of various countries including India are doing research on its medicine. Pharmaceutical company Sun Pharmaceuticals Industries is one of them. The company is preparing a drug based on the plant-derived drug AQCH, which is looking at the possibility of treating corona. The clinical trial of this drug, which is expected to treat corona infection, is in the second phase. The company said in a statement on Friday
Pharmaceutical company Sun Pharmaceuticals Industries said on Friday that it has started a Phase II clinical trial to detect the effect of the plant-derived drug AQCH for possible treatment of Kovid-19 patients.
Sun Pharma said in a statement that the company received approval from the country's top drug regulator Food and Drugs Controller General (FDA) in April last year to test the drug, a drug with medicinal properties, obtained from the plant.

Trial on 210 patients, results till October
The company said that clinical trials of this drug will be done among 210 patients at 12 centers in the country. The treatment period for patients will be 10 days. The clinical trial results are expected by October.

According to the company, AQCH is being developed for dengue. It has been found to have antiviral effects during studies on organisms in controlled environments. Therefore, this drug is being tested as an alternative treatment for Covid-19